Yıl: 2020 Cilt: 27 Sayı: 7 Sayfa Aralığı: 1918 - 1923 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2020.02.161 İndeks Tarihi: 30-10-2020

Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?

Öz:
Aim: Congenital pneumonia (CP) is serious respiratory infection of the neonates. Recently introduced hematological parameter,immature reticulocyte fraction (IRF), has been investigated to gather clinical information about the prognosis of anemia as well asto measure the level of inflammatory activity in adult patients. In this study of late-preterm infants diagnosed with CP, we comparedIRF with common sepsis biomarkers and evaluated its role as inflammatory biomarker in neonates.Material and Methods: Late-preterms were categorized based on infectious vs. non-infectious etiology of the respiratory distress.Blood samples were taken at 48-72 hours after birth. IRF was measured with Sysmex XN-3000. Biomarkers such as complete bloodcount parameters, C-reactive protein (CRP), and procalcitonin (PCT) were used for the comparison.Results: Total of 25 late-preterms, 14 in CP-group and 11 in transient tachypnea of the newborn (TTN) group were included study.The groups were comparable in terms of gestational age, birth weight and cesarean section rate. The proportion of prolongedmembrane rupture was signifiantly higher in CP-group. No signifiant differences were found between hemoglobin, hematocritand reticulocyte in both groups (p>0.05). The value of IRF was higher in CP-group compared to in TTN-group, although it was notstatistically signifiant (37.8±7.2% vs. 31.6±9.4%, respectively) (p=0.08). PCT was signifiantly higher in CP-group (p=0.017). Nodifferences were found in other biomarkers between the groups (p>0.05).Conclusion: Our results suggest that PCT can be diagnostic marker in CP, but further studies are needed to confim role of IRF inneonatal inflammation.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. The Child Health Research Project. Reducing perinatal and neonatal mortality: report of a meeting, Baltimore, Maryland. Baltimore 1999;3:6-12.
  • 2. Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed 2005;90:211-9.
  • 3. Nissen MD. Congenital and neonatal pneumonia. Pediatr Respir Rev 2007;8:195-203.
  • 4. Huang FK, Chen HL, Yang PH, et al. Bird’s eye view of a neonatologist: Clinical Approach to Emergency Neonatal Infection. Pediatr Neonatol 2016;57:167-73.
  • 5. 5. Walsh WF. Neonatal pneumonia. Semin Pediatr Infect Dis 1995;6:166-73.
  • 6. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J 2012;31:799.
  • 7. Chiesa C, Natale F, Pascone R, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011;421:1053-9.
  • 8. Piva E, Brugnara C, Chiandetti L, et al. Automated reticulocyte counting: state of art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med 2010; 48:1369-80.
  • 9. Gonçalo AP, Barbosa IL, Campilho F, et al. Predictive value of immature reticulocyte and platelet fractions in hematopoietic recovery of allograft patients. Transplant Proc 2011;43:241-3.
  • 10. Enz Hubert RM, Rodrigues MV, Andregutto BD, et al. Association of the immature platelet fraction with sepsis diagnosis and severity. Sci Rep 2015;5:8019.
  • 11. Raju TN, Higgins RD, Stark AR, et al. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006;118:1207-14.
  • 12. McIntire DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 2008;111:35-41.
  • 13. Baker RD, Greer FR. Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron defiiency and iron-defiiency anemia in infants and young children (0-3 years of age). Pediatrics 2010;126:1040.
  • 14. American College of Obstetrics and Gynecology, Task Force on Neonatal Encephalopathy and Cerebral Palsy, American Academy of Pediatrics. Neonatal Encephalopathy and Cerebral Palsy: Defiing the Pathogenesis and Pathophysiology. Edited by Washington, DC, American College of Obstetricians and Gynecologists; 2003.
  • 15. Davies PA, Aherne W. Congenital pneumonia. Arch Dis Child 1962;37:598-602.
  • 16. Haney PJ, Bohlman M, Sun CCJ. Radiographic fidings in neonatal pneumonia. Am J Radiology. 1984;143:23- 6.
  • 17. Rawlings JS, Smith FR. Transient tachypnea of the newborn: an analysis of neonatal and obstetric risk factors. Am J Dis of Child 1984;138:869-71.
  • 18. Riley RS, Ben-Ezra JM, Tidwell A, et al. Reticulocyte analysis by flow cytometry and other techniques. Hematol Oncol Clin North Am 2002;16:373-420.
  • 19. Cohen-Wolkowiez M, Moran C, Benjamin DK, et al. Early and late onset sepsis in late preterms. Pediatr Infect Dis J 2009;28:1052-6.
  • 20. Karne TK, Joshi DD, Zile U, et al. Study of platelet count and platelet indices in neonatal sepsis in tertiary care institute. MVP J Med Sci 2017;4:55-60.
  • 21. Edwards MS. Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants. In Up To Date, Kaplan SL, Garcia-Prats JA (Eds), Up To Date 2018. Available from: URL: https://www. uptodate.com access date Oct 16, 2018.
  • 22. Simon L, Saint-Louis P, Amre DK, et al. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med 2008;9:407-13.
  • 23. Stocker M, van Herk W, El Helou S, et al. Procalcitoninguided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicenter, randomized controlled trial (NeoPIns). Lancet 2017;390:871-81.
  • 24. Bonac B, Derganc M, Wraber B, et al. Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates. Pflugers Arch Eur J Physiol 2000;440:72-4.
  • 25. Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systemic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
  • 26. Lencot S, Cabaret B, Sauvage G, et al. A new procalcitonin cord-based algorithm in early-onset neonatal infection: For a change of paradigm. Eur J Clin Microbiol Infect Dis 2014;33:1229-38.
  • 27. Ochi F, Higaki T, Ohta M, et al. Procalcitonin as a marker of respiratory disorder in neonates. Pediatr Int 2015;57:263-8.
  • 28. Bozkaya D, Yigit S, Yurdakok M. Is serum procalcitonin level a reliable indicator in early diagnosis of congenital pneumonia? Turk J Pediatr 2019;61:34-9
  • 29. van Eijk LT, Kroot JJ, Tromp M, et al. Inflammationinduced hepcidin-25 is associated with the development of anemia in septic patients: an observational study. Crit Care 2011;1:9.
  • 30. Nagai Y, Garrett KP, Ohta S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006;24,801-2.
  • 31. Bennett LF, Liao C, Quickel MD, et al. Inflammation induces stress erythropoiesis through hemedependent activation of SPI-C. Sci Signal 2019;12:598,7336.
  • 32. Christensen RD, Henry E, Bennett ST, et al. Reference intervals for reticulocyte parameters of infants during their fist 90 days after birth. J Perinatol 2016;36:61-6.
  • 33. Schiza V, Giapros V, Pantou K, et al. Serum transferrin receptor, ferritin, and reticulocyte maturity indices during the fist year of life in 'large' preterm infants. Eur J Haematol 2007;79:439-46.
  • 34. Buttarello M, Bulian P, Farina G, et al. Five fully automated methods for performing immature reticulocyte fraction: comparison in diagnosis of bone marrow aplasia. Am J Clin Pathol 2002;117:871-9.
  • 35. Redzko S, Przepiesc J, Zak J, et al. Cord blood reticulocytes and reticulocyte subtypes in normal and complicated pregnancy. Med Wieku Rozwoj 2002;6:145-53.
APA ER İ, Çetin C, baydemir c (2020). Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. , 1918 - 1923. 10.5455/annalsmedres.2020.02.161
Chicago ER İlkay,Çetin Ceren,baydemir canan Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. (2020): 1918 - 1923. 10.5455/annalsmedres.2020.02.161
MLA ER İlkay,Çetin Ceren,baydemir canan Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. , 2020, ss.1918 - 1923. 10.5455/annalsmedres.2020.02.161
AMA ER İ,Çetin C,baydemir c Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. . 2020; 1918 - 1923. 10.5455/annalsmedres.2020.02.161
Vancouver ER İ,Çetin C,baydemir c Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. . 2020; 1918 - 1923. 10.5455/annalsmedres.2020.02.161
IEEE ER İ,Çetin C,baydemir c "Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?." , ss.1918 - 1923, 2020. 10.5455/annalsmedres.2020.02.161
ISNAD ER, İlkay vd. "Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?". (2020), 1918-1923. https://doi.org/10.5455/annalsmedres.2020.02.161
APA ER İ, Çetin C, baydemir c (2020). Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. Annals of Medical Research, 27(7), 1918 - 1923. 10.5455/annalsmedres.2020.02.161
Chicago ER İlkay,Çetin Ceren,baydemir canan Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. Annals of Medical Research 27, no.7 (2020): 1918 - 1923. 10.5455/annalsmedres.2020.02.161
MLA ER İlkay,Çetin Ceren,baydemir canan Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. Annals of Medical Research, vol.27, no.7, 2020, ss.1918 - 1923. 10.5455/annalsmedres.2020.02.161
AMA ER İ,Çetin C,baydemir c Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. Annals of Medical Research. 2020; 27(7): 1918 - 1923. 10.5455/annalsmedres.2020.02.161
Vancouver ER İ,Çetin C,baydemir c Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?. Annals of Medical Research. 2020; 27(7): 1918 - 1923. 10.5455/annalsmedres.2020.02.161
IEEE ER İ,Çetin C,baydemir c "Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?." Annals of Medical Research, 27, ss.1918 - 1923, 2020. 10.5455/annalsmedres.2020.02.161
ISNAD ER, İlkay vd. "Can immature reticulocyte fraction be an inflammatory biomarker in late-preterm infants diagnosed with congenital pneumonia?". Annals of Medical Research 27/7 (2020), 1918-1923. https://doi.org/10.5455/annalsmedres.2020.02.161